This inventor holds 2 USPTO granted patents. Top assignees: Merck Patent Gesellschaft MIT Beschraenkter Haftung, Merck Patent Gmbh. Active years: 2002-2003.
Company Filing History:
1 out of 100 
1 out of 3,019 
Years Active: 2002-2003
Title: Jacques Deserprit: Innovator in Pharmaceutical Chemistry
Introduction
Jacques Deserprit is a notable inventor based in Miribel, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of cholesteryl acyl transferase (ACAT) inhibitors. His work has led to the filing of multiple patents that showcase his innovative approach to drug development.
Latest Patents
Jacques Deserprit holds 2 patents related to N-phenylamide and N-pyridylamide derivatives. His latest patents include methods of preparing these compounds and pharmaceutical compositions containing them. The compounds of formula (I) described in his patents are designed to inhibit ACAT, which plays a crucial role in cholesterol metabolism.
Career Highlights
Throughout his career, Jacques has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Merck Patent Gesellschaft mit Beschränkter Haftung and Merck Patent GmbH. His experience in these organizations has allowed him to refine his expertise in patentable innovations in the pharmaceutical sector.
Collaborations
Jacques Deserprit has collaborated with several professionals in his field, including Diedier Festal and Jean Yves Nioche. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Jacques Deserprit's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic agents.